This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Management

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Investigations must include careful palpation for metastatic neck nodes and a direct laryngoscopy and biopsy.

Treatment of early stage disease

Squamous cell carcinoma of the larynx

  • offer transoral laser microsurgery to people with newly-diagnosed T1a squamous cell carcinoma of the glottic larynx
  • offer a choice of transoral laser microsurgery or radiotherapy to people with newly-diagnosed T1b-T2 squamous cell carcinoma of the glottic larynx
  • offer a choice of transoral surgery or radiotherapy to people with newly-diagnosed T1-T2 squamous cell carcinoma of the supraglottic larynx

Treatment of advanced disease

Squamous cell carcinoma of the larynx

  • offer people with T3 squamous cell carcinoma of the larynx a choice of: radiotherapy with concomitant chemotherapy, or surgery with adjuvant radiotherapy, with or without concomitant chemotherapy
  • for people with T4a squamous cell carcinoma of the larynx consider surgery with adjuvant radiotherapy, with or without concomitant chemotherapy

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.